Dummer R, Gyorki DE, Hyngstrom J, Berger AC, et al. Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB-IVM1a melanoma: a randomized, open-label, phase 2 trial. Nat Med 2021 Oct 4. pii: 10.1038/s41591-021-01510.
PMID: 34608333